Search Results 661-670 of 17674 for corticosteroid

  1. A Study to Evaluate the Effectiveness and Safety of PANZYGA in Pediatric Patients with Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

    ... corticosteroid therapy) and a dosage change is planned before Day 32. Note: topical agents and inhaled corticosteroid therapy use is permitted.

  2. A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet - Mayo Clinic

    Has ongoing systemic immunosuppressant, systemic corticosteroid treatment ... corticosteroids in the 12 weeks before Screening. The participant is ...

  3. A Study to Evaluate the Effectiveness and Tolerability of a Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis - Mayo Clinic

    Topical corticosteroids;; Topical bleaching products;; Topical retinoids. Use of systemic preparations within 1 month of study entry, including: Systemic ...

  4. Eosinophils in Human Adipose Tissue - Mayo Clinic

    Receiving corticosteroid therapy. History of severe asthma on chronic steroid therapy. History of COPD or atopic syndrome. History of autoimmune disease ...

  5. Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH) - Mayo Clinic

    * Inhaled corticosteroid + fast-acting ?2 agonist as a reliever (eg Symbicort or Fostair Maintenance and Reliever Treatment) is not allowed 15 days prior to ...

  6. A Study to Evaluate M7824 with Concurrent Chemoradiation (cCRT) in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    ... corticosteroids or systemic corticosteroids at physiological doses, which are not to exceed 10 mg/day of prednisone, or an equivalent corticosteroid.

  7. Antihistamine/decongestant combination (oral route) - Mayo Clinic

    Antihistamine and decongestant combinations are used to treat the nasal congestion (stuffy nose), sneezing, and runny nose caused by colds and hay fever.

  8. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    ... corticosteroids or immunosuppressive agents: NOTE: Inhaled corticosteroids are allowed. One-time antiemetic dose is allowed. Co-morbid systemic illnesses or ...

  9. Uveitis Clinical Trials - Mayo Clinic Research

    ... corticosteroid injection. MERIT is a parallel design (1:1:1), randomized comparative trial with an anniversary close-out at the 6 month clinic visit. The ...

  10. Diagnosis and treatment - Mayo Clinic

    Corticosteroids. These medicines reduce nerve inflammation. For MS, the corticosteroids used are oral prednisone and intravenous methylprednisolone. Side ...